MedTech Spectrum

Article Name Predictive Diagnostics

“We look forward to collaborate with government initiatives to promote degree programmes in biomedical innovation”

Blockchain For Impact (BFI), established during the second wave of the COVID-19 pandemic in India, is continuing its trailblazing journey after announcing a monumental allocation of $15 million through its BFI-BIOME Virtual Network Program, aimed at propelling biomedical research forward in India. In the past three months, BFI has already allocated a substantial amount through strategic MoU’s with elite research institutes and incubators, setting in motion its plans to revolutionise biomedical research and innovation in the country. BioSpectrum India spoke to Sandeep Nailwal, Founder of BFI, in detail about his vision for driving transformative change in the healthcare landscape.

01st August, 2024

Biogennix launches Agilon Surgical Matrix

A safe and effective option for healthcare professionals and patients

24th July, 2024

Japan-based Fujifilm expands health screening service business in Mongolia

New NURA health screening centre opens in Ulaanbaatar

24th July, 2024

Paige demonstrates first clinical-grade performance for cancer detection using a foundation model ‘Virchow’

Paige’s collaboration with Microsoft in AI-driven technology for propelling cancer diagnosis forward

23rd July, 2024

PK MED receives DeepTech financing to develop cell-homing implant

To enhance Bone Marrow Transplantation outcome efficiencies in patients with hematological disorders

24th July, 2024

Menarini announced new cell based non-invasive prenatal technology

Demonstrates high resolution detection of fetal genomic abnormalities from a simple maternal blood draw

02nd July, 2024

Denmark's °MEQU gets US FDA clearance for portable blood & IV-fluid warmer system

System can help in reducing the risk of hypothermia in hemorrhaging patients

07th June, 2024

OrthAlign introduces Lantern handheld technology for knee arthroplasty in Japan

For Total, Partial, and Revision Knee Arthroplasty

14th May, 2024

US based C₂N Diagnostics expands Alzheimer’s diagnostics into Japan

Expands into Japan through Mediford Corporation partnership with Precivity blood testing for Alzheimer’s Disease and brain research market

30th April, 2024

Neuberg Diagnostics forms JV with Sehgal Path Lab to expand haemato-oncology segment

The collaboration will see Sehgal Path Lab rebranded as Neuberg Sehgal Path Lab

29th April, 2024

Owlstone Medical secures $6.5 M to develop breath-based diagnostics for infectious disease

Developing new cost-effective detection technologies for volatile organic compounds (VOCs)

25th April, 2024

Serum Institute of India partners with Univercells to make personalised cancer treatments more accessible

The therapies can reach patients in Europe, India and the African continent

12th April, 2024

IIT Jodhpur develops framework for smartphones-assisted glucose testing device

Allowing diagnostic information to easily be available straight on the phone by simply using an app

28th March, 2024

Cognizant to apply generative AI to enhance drug discovery for pharmaceutical clients with NVIDIA BioNeMo

Cognizant's AI and industry expertise, combined with the NVIDIA BioNeMo generative AI platform, create a strong foundation to improve outcomes in the healthcare and life sciences sectors

20th March, 2024

Vygon spearheads neonatal safety in India with groundbreaking Nutrisafe2 system

First company in the country to launch the enhanced neonatal feeding system

18th March, 2024

Johnson & Johnson Innovation names finalists in atopic advancements QuickPitch

Johnson & Johnson QuickPitch finalists revealed in atopic advancements

13th March, 2024

Bowtie and the Chinese University of Hong Kong Hospital join hands to launch "medical insurance + health" package

Bowtie and CUHK Hospital Unveil Innovative Medical Insurance + Health Package

11th March, 2024

“Early diagnosis through advanced screening tech, coupled with heightened awareness is crucial”

The oncology market in India is steadily growing, driven by an increasing cancer incidence and a strong demand for advanced treatments. However, there remains substantial untapped potential, primarily in improving access to cutting-edge therapies and expanding reach to underserved regions. Glenmark Pharma, with its patient-centric approach and innovative solutions, has been steadily increasing its market share by introducing high-quality and affordable cancer drugs. Alok Malik, President & Business Head - India Formulations, Glenmark Pharmaceuticals Ltd, in an exclusive interview with MedTech Spectrum & BioSpectrum, spoke at length about the company’s mission to enhance access to high-quality cancer care in India and the untapped market potential, new launches and the plans ahead.

28th February, 2024